Key facts
- This page summarizes Michael F. Cola's Form 4 filing for Avalo Therapeutics, Inc. (AVTX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Oct 2021, 16:28.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
100% of this stock option will immediately vest on the date that it is granted. If employment is terminated prior to the end of the calendar quarter in which the option was granted, the number of shares underlying such stock option that reflects the percentage of calendar days remaining in such calendar quarter after such employment termination date shall be forfeited and deemed cancelled.